Evidence map›Paper›PMID 26126690›Full record

ReviewClinical and experimental immunology2015

Permissive and protective roles for neutrophils in leishmaniasis.

E D Carlsen, Y Liang, T R Shelite, D H Walker, P C Melby, L Soong

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Frontiers in immunology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. In and out:Frontiers in cellular and infection microbiology · 2022
    Article
  14. Frontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E D CarlsenDepartment of Internal Medicine, Division of Infectious Diseases, MD-PhD Combined Degree Program.
Y LiangDepartment of Microbiology and Immunology.
T R SheliteDepartment of Pathology.
D H WalkerDepartment of Pathology.
P C MelbyDepartment of Microbiology and Immunology.
L SoongDepartment of Microbiology and Immunology.
The University of Texas Medical Branch at Galveston · US

Funding

Malnutrition-related Lymph Node Dysfunction and Risk of Visceral LeishmaniasisR21AI107419 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MELBY, PETER C. · 2014 to 2015
$426k
Pathogenic Mechanisms of Cutaneous LeishmaniasisR56AI043003 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SOONG, LYNN · 2012 to 2012
$306k
L. Brazilensis Vaccine Antigens and T-cell Quality in ProtectionR03AI103812 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SOONG, LYNN · 2013 to 2014
$155k
NIAID NIH HHS R03 AI103812NIAID NIH HHS R21 AI107419NIAID NIH HHS R56 AI043003
6 · The paper itself

Abstract

Leishmania parasites are the causative agents of leishmaniasis, a neglected tropical disease that causes substantial morbidity and considerable mortality in many developing areas of the world. Recent estimates suggest that roughly 10 million people suffer from cutaneous leishmaniasis (CL), and approximately 76,000 are afflicted with visceral leishmaniasis (VL), which is universally fatal without treatment. Efforts to develop therapeutics and vaccines have been greatly hampered by an incomplete understanding of the parasite's biology and a lack of clear protective correlates that must be met in order to achieve immunity. Although parasites grow and divide preferentially in macrophages, a number of other cell types interact with and internalize Leishmania parasites, including monocytes, dendritic cells and neutrophils. Neutrophils appear to be especially important shortly after parasites are introduced into the skin, and may serve a dual protective and permissive role during the establishment of infection. Curiously, neutrophil recruitment to the site of infection appears to continue into the chronic phase of disease, which may persist for many years. The immunological impact of these cells during chronic leishmaniasis is unclear at this time. In this review we discuss the ways in which neutrophils have been observed to prevent and promote the establishment of infection, examine the role of anti-neutrophil antibodies in mouse models of leishmaniasis and consider recent findings that neutrophils may play a previously unrecognized role in influencing chronic parasite persistence.

Indexed as

AnimalsHost-Parasite InteractionsHumansLeishmaniaLeishmaniasis, CutaneousLeishmaniasis, VisceralMacrophagesMiceNeutrophil InfiltrationNeutrophilsLeishmania, monoclonal antibodymouse modelneutrophil

Identifiers

PMID26126690
PMCPMC4608500
OpenAlexW1569522228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.